Harmonization of molecular monitoring of chronic myeloid leukemia therapy in Japan

Date

2012

Authors

Yoshida, C.
Fletcher, L.
Ohashi, K.
Wakita, H.
Kumagai, T.
Shiseki, M.
Matsuei, K.
Inokuchi, K.
Hatta, Y.
Shirasugi, Y.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

International Journal of Clinical Oncology, 2012; 17(6):584-589

Statement of Responsibility

Chikashi Yoshida, Linda Fletcher, Kazuteru Ohashi, Hisashi Wakita, Takashi Kumagai, Masayuki Shiseki, Kousei Matsuei, Koiti Inokuchi, Yoshihiro Hatta, Yukari Shirasugi, Toshikazu Yamaguchi, Junichi Sakamoto, Susan Branford, Hisashi Sakamaki

Conference Name

Abstract

BACKGROUND: Real-time quantitative polymerase chain reaction (RQ-PCR) has been widely used for molecular monitoring for patients with chronic myeloid leukemia (CML). Currently, RQ-PCR is not based on the concept of international scale (IS) in Japan; mainly because none of the domestic laboratories have obtained their own conversion factor (CF) which makes it possible to convert locally scaled BCR-ABL (BCR-ABL (L)) value to the IS (BCR-ABL (IS)). To join the global trend of molecular assessment of BCR-ABL in CML patients, we have tried to obtain a CF in Japan. METHODS: Samples from 55 patients were exchanged between the Japanese laboratory and the reference laboratory in Adelaide, and BCR-ABL and internal control gene transcripts of the samples were measured using RQ-PCR. The patient bias conversion method was used to determine the CF for the IS using the Bland and Altman method. RESULTS: The local CF in the Japanese laboratory was determined to be 0.87. Based on this CF, 0.1% BCR-ABL (IS), defined as major molecular response, becomes equivalent to 731 copy/μg RNA BCR-ABL (L). CONCLUSION: This study is the first to introduce a laboratory-specific CF for harmonizing RQ-PCR methodology for detecting BCR-ABL transcripts to Japan, which may open new windows for molecular assessment of CML patients in Japan.

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

© Japan Society of Clinical Oncology 2011

License

Grant ID

Call number

Persistent link to this record